M&A Corner
ADC-Focused Firefly Bio Emerges from Stealth with $94M Series A19 Feb 2024
California startup Firefly Bio secures $94 million Series A funding for its innovative cancer treatment platform merging antibody-drug conjugates with... Continue Reading
|
TheracosBio Extends Partnership with Mark Cuban Cost Plus Drug Company19 Feb 2024
TheracosBio extends collaboration with Mark Cuban Cost Plus Drug Company, offering BRENZAVVY® directly to healthcare businesses via Cost Plus Drugs... Continue Reading
|
PIH Health, Medline Expand Prime Vendor Partnership to Service all Points of Care19 Feb 2024
Medline has broadened its prime vendor agreement with PIH Health, a prominent California-based healthcare network, encompassing not only acute care... Continue Reading
|
Medicxi Combines Six Portfolio Companies with $100M to Launch Alys Pharma19 Feb 2024
Medicxi has merged six dermatology-focused companies to create Alys Pharmaceuticals, based in Boston and Switzerland, with a $100 million investment... Continue Reading
|
AbbVie Completes Acquisition of ImmunoGen.19 Feb 2024
AbbVie has successfully acquired ImmunoGen Inc., incorporating ImmunoGen’s ovarian cancer treatment, ELAHERE®, into its oncology pipeline. The $31.26 per share... Continue Reading
|
Everside Health, Marathon Health Announce Merger.13 Feb 2024
Everside Health and Marathon Health are merging to form a unified entity operating under the Marathon Health brand. This consolidation... Continue Reading
|
ObvioHealth, Oracle Life Sciences Expand Partnership Globally13 Feb 2024
ObvioHealth and Oracle Life Sciences are broadening their global partnership following successful trials in the Asia Pacific region. The collaboration... Continue Reading
|
AI for Gut Health: Evogene and Verb Biotics Partner to Advance Probiotic Innovation13 Feb 2024
Evogene Ltd. and Verb Biotics LLC. have joined forces to develop innovative probiotic bacteria strains, aiming to enhance human health... Continue Reading
|
Virgin Pulse, HealthComp Rebrand as Personify Health Following $3B Merger.13 Feb 2024
Virgin Pulse and HealthComp, now rebranded as Personify Health, merge to offer a unified platform for employee wellness and benefits.... Continue Reading
|
Veracyte Completes Acquisition of C2i Genomics13 Feb 2024
Veracyte, Inc. (Nasdaq: VCYT) has finalized its acquisition of C2i Genomics, Inc., enhancing its cancer diagnostics platform with whole-genome minimal... Continue Reading
|